Facebook Twitter LinkedIn Google Plus RSS

Matinas BioPharma moves to Bedminster

By

Biopharmaceutical company Matinas BioPharma Holdings Inc. announced today it has established its corporate headquarters in Bedminster.

According to the announcement, the company, which recently closed a $15 million financing, is now positioned to begin advancing the development of omega-3 lead product candidate, MAT9001, for the treatment of severe hypertriglyceridemia and mixed dyslipidemia.

"We believe [establishing headquarters in New Jersey] strategically positions us very well to have access to great talent and the financial and pharmaceutical communities," Chief Executive Roelof Rongen said in a statement.

Write to the Editorial Department at editorial@njbiz.com

Related Stories

Leave a Comment

test

Please note: All comments will be reviewed and may take up to 24 hours to appear on the site.

Post Comment
View Comment Policy

Comments

close
Subscribe to Our Newsletters!
Click Here to Subscribe for Free Now!